ES8201972A1 - Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina. - Google Patents

Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina.

Info

Publication number
ES8201972A1
ES8201972A1 ES495932A ES495932A ES8201972A1 ES 8201972 A1 ES8201972 A1 ES 8201972A1 ES 495932 A ES495932 A ES 495932A ES 495932 A ES495932 A ES 495932A ES 8201972 A1 ES8201972 A1 ES 8201972A1
Authority
ES
Spain
Prior art keywords
formula
immunoregulatory
pyrimidines
antiinflammatory
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES495932A
Other languages
English (en)
Spanish (es)
Other versions
ES495932A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES495932A0 publication Critical patent/ES495932A0/es
Publication of ES8201972A1 publication Critical patent/ES8201972A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01DHARVESTING; MOWING
    • A01D34/00Mowers; Mowing apparatus of harvesters
    • A01D34/001Accessories not otherwise provided for
    • A01D34/003Means for cleaning the machine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00Moulds or cores; Details thereof or accessories therefor
    • B29C33/56Coatings, e.g. enameled or galvanised; Releasing, lubricating or separating agents
    • B29C33/60Releasing, lubricating or separating agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C70/00Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
    • B29C70/68Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks
    • B29C70/84Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks by moulding material on preformed parts to be joined
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16CSHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00Pivots; Pivotal connections
    • F16C11/04Pivotal connections
    • F16C11/06Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/0604Construction of the male part
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16CSHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00Pivots; Pivotal connections
    • F16C11/04Pivotal connections
    • F16C11/06Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/068Special features relating to lubrication

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • Composite Materials (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES495932A 1979-10-15 1980-10-14 Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina. Expired ES8201972A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/085,011 US4246263A (en) 1979-10-15 1979-10-15 Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ES495932A0 ES495932A0 (es) 1982-01-16
ES8201972A1 true ES8201972A1 (es) 1982-01-16

Family

ID=22188737

Family Applications (2)

Application Number Title Priority Date Filing Date
ES495932A Expired ES8201972A1 (es) 1979-10-15 1980-10-14 Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina.
ES505544A Granted ES505544A0 (es) 1979-10-15 1981-09-16 Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES505544A Granted ES505544A0 (es) 1979-10-15 1981-09-16 Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina

Country Status (39)

Country Link
US (1) US4246263A (en:Method)
JP (1) JPS5663962A (en:Method)
KR (2) KR840001614B1 (en:Method)
AR (3) AR226864A1 (en:Method)
AT (2) AT377513B (en:Method)
AU (1) AU517763B2 (en:Method)
BE (1) BE885709A (en:Method)
CA (1) CA1156231A (en:Method)
CH (1) CH646425A5 (en:Method)
CS (2) CS226020B2 (en:Method)
DD (2) DD154816B3 (en:Method)
DE (1) DE3038593A1 (en:Method)
DK (1) DK152427C (en:Method)
EG (1) EG14676A (en:Method)
ES (2) ES8201972A1 (en:Method)
FI (1) FI75560C (en:Method)
FR (1) FR2467199A1 (en:Method)
GB (2) GB2092133B (en:Method)
GR (1) GR70311B (en:Method)
HK (2) HK1185A (en:Method)
HU (2) HU183233B (en:Method)
IE (1) IE50665B1 (en:Method)
IL (1) IL61261A (en:Method)
IN (2) IN154554B (en:Method)
IT (1) IT1195269B (en:Method)
KE (2) KE3461A (en:Method)
LU (1) LU82844A1 (en:Method)
MY (2) MY8500323A (en:Method)
NL (1) NL8005652A (en:Method)
NO (1) NO156566C (en:Method)
NZ (1) NZ195246A (en:Method)
PH (1) PH18277A (en:Method)
PL (2) PL125314B1 (en:Method)
PT (1) PT71917B (en:Method)
SE (1) SE437023B (en:Method)
SG (2) SG56384G (en:Method)
SU (2) SU1083907A3 (en:Method)
YU (2) YU41740B (en:Method)
ZA (1) ZA806306B (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371696A (en) * 1980-07-14 1983-02-01 Pfizer Inc. Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof
GB8405896D0 (en) * 1984-03-07 1984-04-11 Sandoz Ltd Organic compounds
WO1987007842A1 (en) * 1986-06-17 1987-12-30 Biogen N.V. Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents and methods for treating diseases
WO2003024955A2 (en) * 2001-09-18 2003-03-27 Sunesis Pharmaceuticals, Inc. Small molecule inhibitors of caspases
CA2599169C (en) * 2005-02-25 2013-10-22 Temple University - Of The Commonwealth System Of Higher Education Synthesis of (e)-alpha, beta unsaturated sulfides, sulfones, sulfoxides and sulfonamides
JP5287033B2 (ja) * 2007-08-23 2013-09-11 住友化学株式会社 含フッ素有機硫黄化合物およびその有害節足動物防除剤
CN108530606B (zh) * 2018-04-19 2020-11-20 山东师范大学 一种pH敏感性医用聚氨酯脲材料及其制备方法
CA3115629A1 (en) 2018-10-08 2020-04-16 Ecolab Usa Inc. Sulfide-based compounds and uses thereof
CN110483740B (zh) * 2019-08-12 2021-08-27 山东师范大学 一种聚合物、pH敏感性纳米囊泡及制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409626A (en) * 1963-09-17 1968-11-05 Neisler Lab Inc Indolylethyl pyridinium quaternary ammonium compounds
NL144484B (nl) * 1967-07-26 1975-01-15 Merck & Co Inc Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.
US3558640A (en) * 1967-12-20 1971-01-26 Merck & Co Inc Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
US3636074A (en) * 1968-08-05 1972-01-18 Hooker Chemical Corp Novel mercaptophenol derivatives
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3818009A (en) * 1969-12-29 1974-06-18 Lilly Co Eli Alpha, alpha-disubstituted-5-pyrimidinemethanes
US3676463A (en) 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3707475A (en) 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives

Also Published As

Publication number Publication date
KR830004263A (ko) 1983-07-09
HU191824B (en) 1987-04-28
ES8206478A1 (es) 1982-08-16
NZ195246A (en) 1983-07-15
IE802125L (en) 1981-04-15
KE3466A (en) 1984-11-09
AU517763B2 (en) 1981-08-27
GB2092133B (en) 1983-03-16
BE885709A (fr) 1981-04-14
GB2061928A (en) 1981-05-20
DD202543A5 (de) 1983-09-21
KR840001614B1 (ko) 1984-10-11
KE3461A (en) 1984-10-12
YU42059B (en) 1988-04-30
HU183233B (en) 1984-04-28
GB2061928B (en) 1983-06-02
PT71917A (en) 1980-12-01
SG56384G (en) 1985-03-08
HK1185A (en) 1985-01-11
SU1083907A3 (ru) 1984-03-30
KR840001615B1 (ko) 1984-10-11
AR227576A1 (es) 1982-11-15
JPS5663962A (en) 1981-05-30
YU41740B (en) 1987-12-31
NO803073L (no) 1981-04-21
ES495932A0 (es) 1982-01-16
IT1195269B (it) 1988-10-12
DD154816B3 (de) 1987-05-13
IT8025324A0 (it) 1980-10-14
FI75560B (fi) 1988-03-31
ES505544A0 (es) 1982-08-16
NO156566C (no) 1987-10-14
AR226864A1 (es) 1982-08-31
IL61261A0 (en) 1980-12-31
AR227089A1 (es) 1982-09-15
PH18277A (en) 1985-05-17
ZA806306B (en) 1981-10-28
PL125402B1 (en) 1983-05-31
FR2467199A1 (fr) 1981-04-17
DD154816A5 (de) 1982-04-21
AT377513B (de) 1985-03-25
AT379801B (de) 1986-03-10
NO156566B (no) 1987-07-06
DK152427B (da) 1988-02-29
IL61261A (en) 1984-08-31
DK152427C (da) 1988-07-25
CS226034B2 (en) 1984-03-19
SE8007193L (sv) 1981-04-16
DK403080A (da) 1981-04-16
YU262680A (en) 1983-09-30
FI803239L (fi) 1981-04-16
EG14676A (en) 1985-03-31
IE50665B1 (en) 1986-06-11
IN154554B (en:Method) 1984-11-10
DE3038593C2 (en:Method) 1988-11-10
SG69184G (en) 1985-03-15
SE437023B (sv) 1985-02-04
DE3038593A1 (de) 1981-04-23
IN163553B (en:Method) 1988-10-08
US4246263A (en) 1981-01-20
FR2467199B1 (en:Method) 1984-12-28
MY8500325A (en) 1985-12-31
PL125314B1 (en) 1983-04-30
LU82844A1 (fr) 1981-06-04
ATA508980A (de) 1984-08-15
GR70311B (en:Method) 1982-09-08
MY8500323A (en) 1985-12-31
SU1144617A3 (ru) 1985-03-07
PT71917B (en) 1983-01-10
CA1156231A (en) 1983-11-01
FI75560C (fi) 1988-07-11
ATA268783A (de) 1985-07-15
CS226020B2 (en) 1984-03-19
HK66887A (en) 1987-09-25
PL231782A1 (en:Method) 1982-03-01
GB2092133A (en) 1982-08-11
PL227307A1 (en:Method) 1981-11-13
JPS6129342B2 (en:Method) 1986-07-05
YU266882A (en) 1983-09-30
NL8005652A (nl) 1981-04-21
CH646425A5 (fr) 1984-11-30
AU6324080A (en) 1981-04-30

Similar Documents

Publication Publication Date Title
ES8706130A1 (es) Procedimiento para la preparacion de 3-ariluracilos
ES8601878A1 (es) Procedimiento para preparar nuevas 1-bencil-aminoalquil-pi- rrolidinonas
ES8201972A1 (es) Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina.
ES8500727A1 (es) Procedimiento para la obtencion de derivados de feniletilamina
ES8301980A1 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES8107142A1 (es) Un procedimiento para la preparacion de acetofenonas substi-tuidas
SE8401493D0 (sv) Nya foreningar med farmakologisk aktivitet och even anvendbara som mellanprodukkter
ES8103737A1 (es) Un procedimiento para la preparacion de derivados de urea
SE7904731L (sv) Nya l-leucyl-4-hydroxianilidderivat
ES8304976A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
ES8202000A1 (es) Procedimiento para preparar pirimidil-quinazolinas
ES8603835A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo piridinometoxi sustituido y de sus sales deadicion acidas y cuaternarias
ES8504176A1 (es) Un procedimiento para preparar derivados de esteres del acido propanoico
ES2055708T3 (es) Peptidos.
ES8600297A1 (es) Procedimiento para preparar derivados de imidazol.
ES8603826A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo piperidinopropanolico sustituido y de sus sales de adicion acidas y amonicas cuaternarias
ES8503668A1 (es) Procedimiento para la obtencion de derivados de diaril-imidazol.
ES8801508A1 (es) Procedimiento para la obtencion de n-(fosfonometilglicil)sulfonilaminas de efecto herbicida.
ES8304992A1 (es) Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol y etanodiol.
ES8506600A1 (es) Un procedimiento para la preparacion de derivados de benzamida
JPS5432427A (en) Novel diphenyl ether compounds and herbicides
ES445812A1 (es) Procedimiento para la preparacion de nuevas arilalcohilami- nas sustituidas.
EP0180416A3 (en) Benzoic acid analogues and their production
FI834174A0 (fi) Nya benzazepinderivater, deras framstaellning och deras anvaendning saosom laekemedel
ATE1216T1 (de) Mittel mit diuretischer wirkung enthaltend 2,4-diamino-5-(4-amino-3, 5-dimethoxybenzyl)-pyrimidin und ein kalium-ausschwemmendes diuretikum und deren herstellung.